Australia markets closed

Mayne Pharma Group Limited (MYX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
6.93-0.17 (-2.39%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
268,945
182,390
423,915
400,321
456,601
Cost of revenue
88,969
100,099
253,769
205,577
231,487
Gross profit
179,976
82,291
170,146
194,744
225,114
Operating expenses
Research development
17,594
15,729
14,661
18,910
24,752
Selling general and administrative
182,056
183,998
157,545
106,957
136,029
Total operating expenses
279,595
272,962
253,287
194,055
245,342
Operating income or loss
-99,619
-190,671
-83,141
689
-20,228
Interest expense
22,833
28,389
32,098
32,347
31,057
Total other income/expenses net
-72,006
-65,688
-122,607
-232,443
-91,880
Income before tax
-178,026
-269,698
-217,818
-263,887
-135,367
Income tax expense
80,791
47,745
56,132
-54,805
-40,832
Income from continuing operations
-258,817
-317,443
-273,950
-209,082
-94,535
Net income
-243,323
117,249
-263,343
-208,423
-92,789
Net income available to common shareholders
-243,323
117,249
-263,343
-208,423
-92,789
Basic EPS
1.42
1.42
-3.20
-2.65
-1.21
Diluted EPS
1.41
1.41
-3.20
-2.65
-1.21
Basic average shares
82,177
82,177
82,298
78,575
76,471
Diluted average shares
83,155
83,155
82,298
78,575
76,471